Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-21-017680

EVP and General Counsel sold 220 shares at $55.19 ($12,142)

  • EVP and General Counsel acquired 23,864 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Basil Michelle L EVP and General Counsel 2021-05-18 Grant or award +6,187 21,590 D: show line 1 in the form
Basil Michelle L EVP and General Counsel 2021-05-18 Grant or award +17,677 39,267 D: show line 2 in the form
Basil Michelle L EVP and General Counsel 2021-05-19 Sale −220 $55.19 $12,142 39,047 D: show line 3 in the form
Open-market sales · 220 sh · avg $55.19 · $12,142

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Basil Michelle L EVP and General Counsel 2021-05-18 Grant or award · Non-qualified Stock Option (Right to Buy) +16,737 16,737 D: show line 4 in the form
Loading xslF345X03/form4.xml…